10 likes | 111 Vues
Study comparing progression-free survival in R-CVP responders on rituximab maintenance vs. observation. Analyzing survival percentage and time in years for PFS.
E N D
PFS in R-CVP Responders Receiving R-Maintenance vs Observation • % Survival • Time (years) • PFS=progression free survival; R-CVP=rituximab, cyclophosphamide, vincristine, prednisolone chemotherapy regimen; R-maintenance=rituximab maintenance 1803